Precision Drilling Corporation

5 hours ago · globenewswire.com

39.3 months median overall survival in first-line (1L) R/M immune checkpoint inhibitor naïve patients Company continues to prioritize PDS0301 in metastatic colorectal cancer (mCRC) while pursuing partnership strategy for PDS0101 PRINCETON, N.J., Sept. 22, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced the publication of results from a Phase 2 trial evaluating PDS0101, its HPV16-targeted immunotherapy, in combination with pembrolizumab in the September 17, 2026, issue of JAMA Oncology, a peer reviewed journal of the American Medical Association.

5 days ago · gurufocus.com

On September 16, 2026, Precision Drilling Corp (PDS) shares fell 3.8% to $86.03, continuing a downward trend over the past week. The stock has fluctuated betwee

5 days ago · globenewswire.com

CALGARY, Alberta, Sept. 16, 2026 (GLOBE NEWSWIRE) -- This news release contains “forward-looking information and statements” within the meaning of applicable securities laws. For a full disclosure of the forward-looking information and statements and the risks to which they are subject, see the “Cautionary Statement Regarding Forward-Looking Information and Statements” later in this news release.

11 days ago · seekingalpha.com

Precision Drilling (PDS) has strengthened its balance sheet, reduced debt, and operates a premium rig fleet with increasing activity, especially in Canada. Q2 revenue grew 11% to C$452.8M, but adjusted EBITDA fell 10% due to reactivation and upgrade costs, highlighting the need for margin recovery, particularly in the U.S. Contracted rigs in both Canada and the U.S. provide greater revenue visibility, but future margin improvement, especially from U.S. rigs, remains a key catalyst and risk.

14 days ago · globenewswire.com

Dr. Soon-Shiong will Join PDS Biotech's Board of Directors PDS Biotech Plans to Progress Development of PDS0301 Immunocytokine in Solid Tumors PRINCETON, N.J., Sept. 08, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) ("PDS Biotech" or the "Company"), a clinical-stage biotechnology company focused on developing targeted immunotherapies for cancer, today announced it has raised up to $22.55 million in equity funding in a Private Investment in Public Equity (“PIPE”) transaction.

1 month ago · globenewswire.com

PRINCETON, N.J., Aug. 13, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a clinical-stage biotechnology company focused on developing targeted immunotherapies for cancer, today provided a business and clinical programs update and reported financial results for the quarter ended June 30, 2026.

1 month ago · benzinga.com

PDS Biotechnology Corporation (NASDAQ:PDSB) shares have fallen by about 67% on Tuesday as the company announced a strategic refocus on its PDS0301 program for metastatic colorectal cancer.

2 months ago · zacks.com

Precision Drilling (PDS) came out with a quarterly loss of $0.38 per share versus the Zacks Consensus Estimate of $0.43. This compares to earnings of $0.77 per share a year ago.

2 months ago · globenewswire.com

CALGARY, Alberta, July 28, 2026 (GLOBE NEWSWIRE) -- This news release contains “forward-looking information and statements” within the meaning of applicable securities laws. For a full disclosure of the forward-looking information and statements and the risks to which they are subject, see the “Cautionary Statement Regarding Forward-Looking Information and Statements” later in this news release. This news release contains references to certain Financial Measures and Ratios, including Adjusted EBITDA (earnings before income taxes, (gain) loss on investments and other assets, finance charges, foreign exchange, gain on asset disposals and depreciation and amortization), Net Capital Spending, Working Capital and Total Long-Term Financial Liabilities. These terms do not have standardized meanings prescribed under International Financial Reporting Standards ( IFRS ) Accounting Standards and may not be comparable to similar measures used by other companies. See “Financial Measures and Ratios” later in this news release.

2 months ago · globenewswire.com

CALGARY, Alberta, July 13, 2026 (GLOBE NEWSWIRE) -- Precision Drilling Corporation announced today that Alice Wong has advised the Company that she will step down from the Board of Directors, effective immediately.